Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
Nat Ecol Evol ; 3(5): 722-723, 2019 05.
Article in English | MEDLINE | ID: mdl-30988493

Subject(s)
Crop Production
2.
Sci Rep ; 8(1): 14377, 2018 09 26.
Article in English | MEDLINE | ID: mdl-30258205

ABSTRACT

PTEN-induced putative kinase (PINK) 1 is regarded as a master regulator of cellular mitophagy such that loss of function mutations contribute to early onset Parkinson's disease, through aberrant mitochondrial control and function. Mitochondrial function is key to platelet procoagulant activity, controlling the haemostatic response to vessel injury, but can also predispose blood vessels to thrombotic complications. Here, we sought to determine the role of PINK1 in platelet mitochondrial health and function using PINK1 knockout (KO) mice. The data largely show an absence of such a role. Haematological analysis of blood counts from KO mice was comparable to wild type. Quantification of mitochondrial mass by citrate synthase activity assay or expression of mitochondrial markers were comparable, suggesting normal mitophagy in KO platelets. Analysis of mitochondrial permeability transition pore opening, changes in mitochondrial membrane potential and calcium signalling to platelet activation were unaffected by loss of PINK1, whereas subtle enhancements of activation-induced reactive oxygen species were detected. Platelet aggregation, integrin activation, α- and dense granule secretion and phosphatidylserine exposure were unaltered in KO platelets while mouse tail bleeding responses were similar to wild type. Together these results demonstrate that PINK1 does not regulate basal platelet mitophagy and is dispensable for platelet function.


Subject(s)
Blood Platelets/metabolism , Mitochondria/genetics , Protein Kinases/genetics , Animals , Blood Platelets/cytology , Gene Deletion , Membrane Potential, Mitochondrial , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Mitochondrial Permeability Transition Pore , Mitophagy , Platelet Activation , Protein Kinases/metabolism
3.
Philos Trans A Math Phys Eng Sci ; 376(2119)2018 May 13.
Article in English | MEDLINE | ID: mdl-29610383

ABSTRACT

We projected changes in weather extremes, hydrological impacts and vulnerability to food insecurity at global warming of 1.5°C and 2°C relative to pre-industrial, using a new global atmospheric general circulation model HadGEM3A-GA3.0 driven by patterns of sea-surface temperatures and sea ice from selected members of the 5th Coupled Model Intercomparison Project (CMIP5) ensemble, forced with the RCP8.5 concentration scenario. To provide more detailed representations of climate processes and impacts, the spatial resolution was N216 (approx. 60 km grid length in mid-latitudes), a higher resolution than the CMIP5 models. We used a set of impacts-relevant indices and a global land surface model to examine the projected changes in weather extremes and their implications for freshwater availability and vulnerability to food insecurity. Uncertainties in regional climate responses are assessed, examining ranges of outcomes in impacts to inform risk assessments. Despite some degree of inconsistency between components of the study due to the need to correct for systematic biases in some aspects, the outcomes from different ensemble members could be compared for several different indicators. The projections for weather extremes indices and biophysical impacts quantities support expectations that the magnitude of change is generally larger for 2°C global warming than 1.5°C. Hot extremes become even hotter, with increases being more intense than seen in CMIP5 projections. Precipitation-related extremes show more geographical variation with some increases and some decreases in both heavy precipitation and drought. There are substantial regional uncertainties in hydrological impacts at local scales due to different climate models producing different outcomes. Nevertheless, hydrological impacts generally point towards wetter conditions on average, with increased mean river flows, longer heavy rainfall events, particularly in South and East Asia with the most extreme projections suggesting more than a doubling of flows in the Ganges at 2°C global warming. Some areas are projected to experience shorter meteorological drought events and less severe low flows, although longer droughts and/or decreases in low flows are projected in many other areas, particularly southern Africa and South America. Flows in the Amazon are projected to decline by up to 25%. Increases in either heavy rainfall or drought events imply increased vulnerability to food insecurity, but if global warming is limited to 1.5°C, this vulnerability is projected to remain smaller than at 2°C global warming in approximately 76% of developing countries. At 2°C, four countries are projected to reach unprecedented levels of vulnerability to food insecurity.This article is part of the theme issue 'The Paris Agreement: understanding the physical and social challenges for a warming world of 1.5°C above pre-industrial levels'.

4.
Sci Rep ; 7(1): 9902, 2017 08 29.
Article in English | MEDLINE | ID: mdl-28851986

ABSTRACT

Children suffering from autism have been reported to have low bone mineral density and increased risk for fracture, yet the cellular origin of the bone phenotype remains unknown. Here we have utilized a mouse model of autism that duplicates 6.3 Mb region of chromosome 7 (Dp/+) corresponding to a region of chromosome 15q11-13, duplication of which is recurrent in humans to characterize the bone phenotype. Paternally inherited Dp/+ (patDp/+) mice showed expected increases in the gene expression in bone, normal postnatal growth and body weight acquisition compared to the littermate controls. Four weeks-old patDp/+ mice develop a low bone mass phenotype in the appendicular but not the axial skeleton compared to the littermate controls. This low bone mass in the mutant mice was secondary to a decrease in the number of osteoblasts and bone formation rate while the osteoclasts remained relatively unaffected. Further in vitro cell culture experiments and gene expression analysis revealed a major defect in the proliferation, differentiation and mineralization abilities of patDp/+ osteoblasts while osteoclast differentiation remained unchanged compared to controls. This study therefore characterizes the structural and cellular bone phenotype in a mouse model of autism that can be further utilized to investigate therapeutic avenues to treat bone fractures in children with autism.


Subject(s)
Autistic Disorder/genetics , Autistic Disorder/pathology , Bone and Bones/pathology , Chromosome Duplication , Chromosomes, Human, Pair 15 , Animals , Autistic Disorder/metabolism , Bone and Bones/diagnostic imaging , Disease Models, Animal , Female , Genetic Association Studies , Genetic Loci , Humans , Male , Mice , Mice, Knockout , Organ Size , Osteoblasts/metabolism , Phenotype , X-Ray Microtomography
5.
J Pineal Res ; 63(2)2017 Sep.
Article in English | MEDLINE | ID: mdl-28512916

ABSTRACT

Tryptophan, an essential amino acid through a series of enzymatic reactions gives rise to various metabolites, viz. serotonin and melatonin, that regulate distinct biological functions. We show here that tryptophan metabolism in the pineal gland favors bone mass accrual through production of melatonin, a pineal-derived neurohormone. Pineal gland-specific deletion of Tph1, the enzyme that catalyzes the first step in the melatonin biosynthesis lead to a decrease in melatonin levels and a low bone mass due to an isolated decrease in bone formation while bone resorption parameters remained unaffected. Skeletal analysis of the mice deficient in MT1 or MT2 melatonin receptors showed a low bone mass in MT2-/- mice while MT1-/- mice had a normal bone mass compared to the WT mice. This low bone mass in the MT2-/- mice was due to an isolated decrease in osteoblast numbers and bone formation. In vitro assays of the osteoblast cultures derived from the MT1-/- and MT2-/- mice showed a cell intrinsic defect in the proliferation, differentiation and mineralization abilities of MT2-/- osteoblasts compared to WT counterparts, and the mutant cells did not respond to melatonin addition. Finally, we demonstrate that daily oral administration of melatonin can increase bone accrual during growth and can cure ovariectomy-induced structural and functional degeneration of bone by specifically increasing bone formation. By identifying pineal-derived melatonin as a regulator of bone mass through MT2 receptors, this study expands the role played by tryptophan derivatives in the regulation of bone mass and underscores its therapeutic relevance in postmenopausal osteoporosis.


Subject(s)
Bone and Bones/metabolism , Melatonin/pharmacology , Osteoblasts/metabolism , Pineal Gland/metabolism , Receptor, Melatonin, MT2/metabolism , Signal Transduction/drug effects , Animals , Bone and Bones/pathology , Calcification, Physiologic/drug effects , Female , Humans , Melatonin/metabolism , Mice , Mice, Knockout , Organ Size/drug effects , Osteoblasts/pathology , Osteoporosis, Postmenopausal/drug therapy , Osteoporosis, Postmenopausal/genetics , Osteoporosis, Postmenopausal/metabolism , Osteoporosis, Postmenopausal/pathology , Pineal Gland/pathology , Receptor, Melatonin, MT1/genetics , Receptor, Melatonin, MT1/metabolism , Receptor, Melatonin, MT2/genetics , Signal Transduction/genetics
6.
Future Cardiol ; 12(3): 339-49, 2016 05.
Article in English | MEDLINE | ID: mdl-27091483

ABSTRACT

This review introduces a new hypothesis that sympathetically mediated hypertensive diseases are caused, in the most part, by the activation of visceral afferent systems that are connected to neural circuits generating sympathetic activity. We consider how organ hypoperfusion and blood flow supply-demand mismatch might lead to both sensory hyper-reflexia and aberrant afferent tonicity. We discuss how this may drive sympatho-excitatory-positive feedback and extend across multiple organs initiating, or at least amplifying, sympathetic hyperactivity. The latter, in turn, compounds the challenge to sufficient organ blood flow through heightened vasoconstriction that both maintains and exacerbates hypertension.


Subject(s)
Feedback, Physiological , Hypertension/etiology , Regional Blood Flow/physiology , Sympathetic Nervous System/physiopathology , Afferent Pathways/physiology , Carotid Body/blood supply , Efferent Pathways/physiology , Hemodynamics , Homeostasis , Humans , Hypertension/physiopathology , Kidney/blood supply , Kidney/innervation , Muscle, Skeletal/blood supply , Muscle, Skeletal/innervation , Vascular Resistance
7.
J Clin Invest ; 124(7): 2988-3002, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24911144

ABSTRACT

Both maternal and offspring-derived factors contribute to lifelong growth and bone mass accrual, although the specific role of maternal deficiencies in the growth and bone mass of offspring is poorly understood. In the present study, we have shown that vitamin B12 (B12) deficiency in a murine genetic model results in severe postweaning growth retardation and osteoporosis, and the severity and time of onset of this phenotype in the offspring depends on the maternal genotype. Using integrated physiological and metabolomic analysis, we determined that B12 deficiency in the offspring decreases liver taurine production and associates with abrogation of a growth hormone/insulin-like growth factor 1 (GH/IGF1) axis. Taurine increased GH-dependent IGF1 synthesis in the liver, which subsequently enhanced osteoblast function, and in B12-deficient offspring, oral administration of taurine rescued their growth retardation and osteoporosis phenotypes. These results identify B12 as an essential vitamin that positively regulates postweaning growth and bone formation through taurine synthesis and suggests potential therapies to increase bone mass.


Subject(s)
Bone Development/physiology , Growth/physiology , Taurine/biosynthesis , Vitamin B 12/metabolism , Animals , Bone Density/physiology , Female , Growth Disorders/etiology , Growth Disorders/metabolism , Growth Hormone/metabolism , Insulin-Like Growth Factor I/biosynthesis , Intrinsic Factor/deficiency , Intrinsic Factor/genetics , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Osteoporosis/etiology , Osteoporosis/metabolism , Pregnancy , Pregnancy Complications/genetics , Pregnancy Complications/metabolism , Prenatal Exposure Delayed Effects , STAT5 Transcription Factor/metabolism , Taurine/administration & dosage , Vitamin B 12 Deficiency/complications , Vitamin B 12 Deficiency/genetics
8.
Arterioscler Thromb Vasc Biol ; 33(12): 2740-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24135020

ABSTRACT

OBJECTIVE: Dietary flavonoids have long been appreciated in reducing cardiovascular disease risk factors, but their mechanisms of action are complex in nature. In this study, the effects of tangeretin, a dietary flavonoid, were explored on platelet function, signaling, and hemostasis. APPROACH AND RESULTS: Tangeretin inhibited agonist-induced human platelet activation in a concentration-dependent manner. It inhibited agonist-induced integrin αIIbß3 inside-out and outside-in signaling, intracellular calcium mobilization, and granule secretion. Tangeretin also inhibited human platelet adhesion and subsequent thrombus formation on collagen-coated surfaces under arterial flow conditions in vitro and reduced hemostasis in mice. Further characterization to explore the mechanism by which tangeretin inhibits platelet function revealed distinctive effects of platelet signaling. Tangeretin was found to inhibit phosphoinositide 3-kinase-mediated signaling and increase cGMP levels in platelets, although phosphodiesterase activity was unaffected. Consistent with increased cGMP levels, tangeretin increased the phosphorylation of vasodilator-stimulated phosphoprotein at S239. CONCLUSIONS: This study provides support for the ability and mechanisms of action of dietary flavonoids to modulate platelet signaling and function, which may affect the risk of thrombotic disease.


Subject(s)
Blood Platelets/drug effects , Flavones/pharmacology , Hemostasis/drug effects , Phosphoinositide-3 Kinase Inhibitors , Platelet Activation/drug effects , Platelet Aggregation Inhibitors/pharmacology , Protein Kinase Inhibitors/pharmacology , Second Messenger Systems/drug effects , Thrombosis/prevention & control , Animals , Blood Platelets/enzymology , Calcium Signaling/drug effects , Cell Adhesion Molecules/blood , Cyclic GMP/blood , Dose-Response Relationship, Drug , Humans , Mice , Mice, Inbred C57BL , Microfilament Proteins/blood , Phosphatidylinositol 3-Kinase/blood , Phosphoproteins/blood , Phosphorylation , Platelet Adhesiveness/drug effects , Platelet Aggregation/drug effects , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Proto-Oncogene Proteins c-akt/blood , Thrombosis/blood , Time Factors
9.
Nat Commun ; 4: 2564, 2013.
Article in English | MEDLINE | ID: mdl-24096827

ABSTRACT

The presence of multiple connexins was recently demonstrated in platelets, with notable expression of Cx37. Studies with Cx37-deficient mice and connexin inhibitors established roles for hemichannels and gap junctions in platelet function. It was uncertain, however, whether Cx37 functions alone or in collaboration with other family members through heteromeric interactions in regulation of platelet function. Here we report the presence and functions of an additional platelet connexin, Cx40. Inhibition of Cx40 in human platelets or its deletion in mice reduces platelet aggregation, fibrinogen binding, granule secretion and clot retraction. The effects of the Cx37 inhibitor (37,43)Gap27 on Cx40(-/-) mouse platelets and of the Cx40 inhibitor (40)Gap27 on Cx37(-/-) mouse platelets revealed that each connexin is able to function independently. Inhibition or deletion of Cx40 reduces haemostatic responses in mice, indicating the physiological importance of this protein in platelets. We conclude that multiple connexins are involved in regulating platelet function, thereby contributing to haemostasis and thrombosis.


Subject(s)
Blood Coagulation/drug effects , Blood Platelets/metabolism , Connexins/genetics , Platelet Aggregation/drug effects , Animals , Blood Platelets/drug effects , Blood Platelets/pathology , Cell Communication , Cell Degranulation/drug effects , Connexins/antagonists & inhibitors , Connexins/deficiency , Endothelial Cells/cytology , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Gap Junctions/metabolism , Gene Expression , Humans , Mice , Mice, Knockout , Peptides/pharmacology , Platelet Activation/drug effects , Signal Transduction , Gap Junction alpha-5 Protein , Gap Junction alpha-4 Protein
10.
J Clin Microbiol ; 44(3): 854-6, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16517866

ABSTRACT

The use of automated systems in the modern microbiology laboratory is becoming commonplace as the pressure of cost containment impacts on staff resources. With increased international travel and threats of bioterrorism, recognition and accurate identification of organisms such as Burkholderia pseudomallei is important. In areas where this organism is endemic, identification is not usually problematic. This study evaluates the performance of the new VITEK 2 colorimetric GN card for the identification of this organism. A total of 103 previously identified clinical isolates were tested with the new card with isolates taken from MacConkey agar, Columbia horse blood agar, Columbia sheep blood agar, and Trypticase soy agar in order to determine identification performance and to see if there was any variability in results due to the agar. Columbia horse blood agar produced the highest rates of identification (81%), followed by Trypticase soy agar (78%), Columbia sheep blood agar (75%), and MacConkey agar (63%). There was considerable variability in some of the reactions obtained. Seven isolates failed to identify from any of the agars used. This study highlights issues with the identification of this organism with the new VITEK 2 GN card. Enhancements of the algorithm parameters for the GN card are warranted and are in progress. Laboratory personnel need to be aware of the current limitations with this GN card and the software (version 4.02 or older for the VITEK 2 60/XL and version 1.02 or older for VITEK 2 Compact) and rely on clinical history, a high index of suspicion, and basic microbiology tests to confirm the identification of this organism.


Subject(s)
Bacteriological Techniques/methods , Burkholderia pseudomallei/isolation & purification , Colorimetry/methods , Agar , Animals , Automation , Bacteriological Techniques/instrumentation , Blood , Caseins , Colorimetry/instrumentation , Culture Media , Horses , Humans , Protein Hydrolysates , Sheep
SELECTION OF CITATIONS
SEARCH DETAIL